Epic Therapeutics Acquired by Baxter International
TM Capital advised Epic Therapeutics in its acquisition by Baxter Healthcare Corporation (NYSE:BAX) subsequent to a collaboration agreement and investment by Baxter
Freedom Innovations Completes Leveraged Recap
TM Capital advised Freedom Innovations and ACT Medical in a leveraged recapitalization led by Telegraph Hill Partners and Tailwind Capital Group whereby they acquired a 73% stake in the combined company
DCN Receives Growth Equity Investment from Martis Capital
TM Capital served as financial advisor to DCN Dx in connection with a growth equity investment from Martis Capital